If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

What does the shingles rash looks like? Who’s at risk? And who needs the shingles vaccine? Get your questions answered in this WebMD slideshow. There are some common misconceptions about this ...

Shingrix is approved to prevent shingles (herpes zoster ... Also Read: GSK Halts Herpes Simplex Virus Vaccine Development, Clears Path For Other Contenders Like Moderna, BioNTech.

Findings showed a noninferior immune response for both vaccines when coadministered compared with separate administration. Topline results were announced from a phase 3 study assessing the immune ...

GSK recorded positive topline data in a late stage trial of its respiratory syncytial virus vaccine combined with a shingles vaccine in treating adults 50 years and older. The British pharma giant ...

Researchers conducted an observational study to compare the risk for dementia associated with both the live and recombinant shingles vaccines. The recombinant herpes zoster (shingles) vaccine is ...

A vaccine for the prevention of shingles in adults aged 50 and over and those aged 18 and over at increased risk KUALA LUMPUR, Malaysia, Sept. 13, 2024 /PRNewswire/ -- GlaxoSmithKline ...

(Reuters) -British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot together generated the same immune response in a late-stage ...

Trial met primary endpoint, non-inferior immune response for both vaccines when co-administered compared with separate administration Co-administration of the RSV and shingles adjuvanted vaccines ...

A vaccine for the prevention of shingles in adults aged 50 and over and those aged 18 and over at increased risk (from left to right) Dr Alap Gandhi, Country Medical Director of GSK Malaysia and ...